Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of EVT 201 (Dimdazenil) in Primary Insomnia
NCT00380003Phase 2Completed
- Sponsor
- Evotec SE
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dimdazenil in Insomnia (3 arms), sponsored by Evotec SE. Primary endpoints: Total Sleep Time and Wake After Sleep Onset. Started Sep 2006; status: completed.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00380003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380003.